Evidence Library
Filter by drug, type, year, and open access.
Showing 1–5 of 5 results
- Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials — Journal of Drug Assessment (2020)• Drug: lofexidineOpen accessDOIPMIDPMCID
- Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial — Journal of Addiction Medicine (2019)• Drug: lofexidineOpen accessDOIPMIDPMCID
- The Role of Lofexidine in Management of Opioid Withdrawal — Pain Therapy (2019)• Drug: lofexidineOpen accessDOIPMIDPMCID
- A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal — Drug and Alcohol Dependence (2017)• Drug: lofexidineDOIPMID
- Alpha₂-adrenergic agonists for the management of opioid withdrawal — Cochrane Database of Systematic Reviews (2016)• Drug: lofexidineOpen accessDOIPMIDPMCID